The definitive forensic engine for quantifying Ovarian Cancer & Mesothelioma damages following the Texas Two-Step Bankruptcy Rejections.
67,622+
Consolidated Claims
MDL 2738
Target MDL
$4.9B
Jury High-Water
REJECTED
Bankruptcy Status
Quantifying Paratubal Serous and High-Grade Serous Ovarian Carcinoma values based on Fallopian Staging.
Analyzing the 'Texas Two-Step' failure and how individual trial paths create a 1.5x valuation premium.
Cross-referencing your case against the $5B+ award history and J&J's rejected $9B reserve allocations.
Federal MDL statistics confirm that claimants with specialized mass tort representation secure settlement values significantly higher than pro se filings, due to precise 'Oncology Point System' documentation.
Calibrated against the 2026 Special Master benchmark reports and IARC Monograph 129 carcinogen markers.
Launch Precise AuditorThe continuous rejection of bankruptcy filings (Chapter 11) for J&J subsidiaries means claimants are NOT forced into a limited-fund trust. This preserves your 'General Duty' breach claims and allows for significantly higher individual jury awards.
Forensic discovery has proven that talc deposits and asbestos are naturally found in the same geological veins. If your biopsy shows mineral contamination, your case may be eligible for a 'Mesothelioma-tier' multiplier, often 1.35x higher than base ovarian cases.
No. While J&J defense often cites genetic predisposition, S-Class legal strategies argue that talc usage served as an 'Aggravating Trigger' or 'Sequential Cause.' Our engine applies a sensitivity weight (0.85x) to provide a realistic trial-readiness valuation.